Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01031264 · ClinicalTrials.gov registry record

Chronic Alcohol and Brain Stress Circuit Response

A clinical trial of Stress and Alcoholism, sponsored by Yale University.

Completed
Registry status
120
Enrollment target
1
Study location

NCT01031264: Completed study of Stress and Alcoholism, sponsored by Yale University.

NCT01031264 is a study of Stress and Alcoholism that has completed, run by Yale University. The registered enrollment target is 120 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01031264, a study of Stress and Alcoholism, has completed, sponsored by Yale University.

COMPLETED
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

Alcoholism is among the top three causes of preventable death and disease in the US (Mokdad et al., 2004; Room et al., 2005). Stress plays an important role in the development of alcoholism and in high vulnerability to alcohol relapse. This study will provide a greater understanding of the mechanism by which stress and alcohol consumption interacts to influence development of compulsive alcohol seeking and vulnerability to stress-induced drinking, and the results will have significant implications for the development of new prevention and treatment interventions for alcoholism.

Primary Outcome

Physiological measures will be collected (heart rate, blood levels), self-reports of emotional states completed \& alcohol taste task performed

Conditions Studied

Study Locations (1)

Connecticut

  • Yale Stress Center - New Haven

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-01
Est. Completion 2014-12
Yale University

1,492 total trials

What the finished NCT01031264 record still lists

NCT01031264 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 0 interventions.

NCT01031264 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT01031264 about?

NCT01031264 is a clinical study titled "Chronic Alcohol and Brain Stress Circuit Response". Alcoholism is among the top three causes of preventable death and disease in the US (Mokdad et al., 2004; Room et al., 2005). Stress plays an important role in the development of alcoholism and in high vulnerability to alcohol relapse. This study will provide a greater understanding of the mechanism...

What is the current status of trial NCT01031264?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2009-01. Estimated completion is 2014-12.

What conditions does trial NCT01031264 study?

This clinical trial studies the following conditions: Stress, Alcoholism.

Who is sponsoring clinical trial NCT01031264?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01031264 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01031264's enrollment target sits among peer trials

120 52nd of 152 higher than 94 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01031264, the US trial registry maintained by the National Library of Medicine. NCT01031264 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.